Avantor (NYSE:AVTR) Issues Earnings Results

Avantor (NYSE:AVTR) posted its earnings results on Friday. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02, RTT News reports. Avantor had a net margin of 4.54% and a return on equity of 12.24%. During the same period in the previous year, the firm posted $0.22 EPS.

Avantor Stock Down 9.2 %

AVTR traded down $2.01 on Friday, reaching $19.69. The company’s stock had a trading volume of 8,362,423 shares, compared to its average volume of 4,967,080. The business’s 50 day moving average is $21.76 and its 200 day moving average is $23.46. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. Avantor has a 1 year low of $19.48 and a 1 year high of $28.00. The stock has a market cap of $13.40 billion, a price-to-earnings ratio of 42.75, a price-to-earnings-growth ratio of 3.97 and a beta of 1.28.

Analysts Set New Price Targets

AVTR has been the topic of a number of recent analyst reports. UBS Group reissued a “neutral” rating and issued a $25.00 price target (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Barclays upped their price target on Avantor from $25.00 to $26.00 and gave the company an “overweight” rating in a report on Monday. Wells Fargo & Company lowered their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Robert W. Baird decreased their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Finally, Raymond James decreased their price target on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a report on Tuesday, January 21st. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $27.46.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.